MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3. 2010

Hiroyuki Hirai, and Mayank Verma, and Shuichi Watanabe, and Christopher Tastad, and Yoko Asakura, and Atsushi Asakura
Stem Cell Institute, Department of Neurology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

The molecules that regulate the apoptosis cascade are also involved in differentiation and syncytial fusion in skeletal muscle. MyoD is a myogenic transcription factor that plays essential roles in muscle differentiation. We noticed that MyoD(-/-) myoblasts display remarkable resistance to apoptosis by down-regulation of miR-1 (microRNA-1) and miR-206 and by up-regulation of Pax3. This resulted in transcriptional activation of antiapoptotic factors Bcl-2 and Bcl-xL. Forced MyoD expression induces up-regulation of miR-1 and miR-206 and down-regulation of Pax3, Bcl-2, and Bcl-xL along with increased apoptosis in MyoD(-/-) myoblasts. In contrast, MyoD gene knockdown increases cell survival of wild-type myoblasts. The 3' untranslated region of Pax3 mRNA contains two conserved miR-1/miR-206-binding sites, which are required for targeting of these microRNAs (miRNAs). Therefore, these data suggest that MyoD not only regulates terminal differentiation but also apoptosis through miRNA-mediated down-regulation of Pax3. Finally, MyoD, miR-1, and miR-206 are all down-regulated in quiescent satellite cells, which may be required for maintenance of muscle stem cells.

UI MeSH Term Description Entries
D012038 Regeneration The physiological renewal, repair, or replacement of tissue. Endogenous Regeneration,Regeneration, Endogenous,Regenerations
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D000072041 PAX3 Transcription Factor A paired box transcription factor that functions in CELL PROLIFERATION; CELL MIGRATION; and APOPTOSIS. It also is involved in MYOGENESIS and neural development. Mutations in the PAX3 gene are associated with WAARDENBURG SYNDROME TYPE 1. Paired Box 3 Protein,Paired Box Transcription Factor 3,Transcription Factor PAX3,Factor PAX3, Transcription,PAX3, Transcription Factor,Transcription Factor, PAX3
D015533 Transcriptional Activation Processes that stimulate the GENETIC TRANSCRIPTION of a gene or set of genes. Gene Activation,Genetic Induction,Transactivation,Induction, Genetic,Trans-Activation, Genetic,Transcription Activation,Activation, Gene,Activation, Transcription,Activation, Transcriptional,Genetic Trans-Activation,Trans Activation, Genetic
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D017570 MyoD Protein A myogenic regulatory factor that controls myogenesis. Though it is not clear how its function differs from the other myogenic regulatory factors, MyoD appears to be related to fusion and terminal differentiation of the muscle cell. MyoD Factor,Factor, MyoD,Protein, MyoD
D051020 bcl-X Protein A member of the bcl-2 protein family that plays a role in the regulation of APOPTOSIS and is a regulatory subunit for PROTEIN PHOSPHATASE 1. Two major isoforms of the protein exist due to ALTERNATIVE SPLICING of the BCL2L1 mRNA and are referred to as Bcl-XS and Bcl-XL. bcl-XL Protein,bcl-XS Protein,bcl-X(L) Protein,bcl-X(S) Protein,bcl-Xa Protein,bcl-Xalpha Protein,bcl-Xb Protein,bcl-Xbeta Protein,bcl-Xlong Protein,bcl-Xshort Protein,bcl-x(beta) Protein,bcl2-Like 1 Protein,bcl2L1 Protein,bcl X Protein,bcl XL Protein,bcl XS Protein,bcl Xa Protein,bcl Xalpha Protein,bcl Xb Protein,bcl Xbeta Protein,bcl Xlong Protein,bcl Xshort Protein,bcl2 Like 1 Protein
D051761 Paired Box Transcription Factors A family of transcription factors that control EMBRYONIC DEVELOPMENT within a variety of cell lineages. They are characterized by a highly conserved paired DNA-binding domain that was first identified in DROSOPHILA segmentation genes. Paired Box Transcription Factor,Pax Transcription Factor,Pax Transcription Factors,Factor, Pax Transcription,Transcription Factor, Pax,Transcription Factors, Pax

Related Publications

Hiroyuki Hirai, and Mayank Verma, and Shuichi Watanabe, and Christopher Tastad, and Yoko Asakura, and Atsushi Asakura
April 2010, The Journal of biological chemistry,
Hiroyuki Hirai, and Mayank Verma, and Shuichi Watanabe, and Christopher Tastad, and Yoko Asakura, and Atsushi Asakura
November 2002, Journal of neuro-oncology,
Hiroyuki Hirai, and Mayank Verma, and Shuichi Watanabe, and Christopher Tastad, and Yoko Asakura, and Atsushi Asakura
February 2006, The Journal of biological chemistry,
Hiroyuki Hirai, and Mayank Verma, and Shuichi Watanabe, and Christopher Tastad, and Yoko Asakura, and Atsushi Asakura
September 2015, Oncotarget,
Hiroyuki Hirai, and Mayank Verma, and Shuichi Watanabe, and Christopher Tastad, and Yoko Asakura, and Atsushi Asakura
August 2018, Molecular medicine reports,
Hiroyuki Hirai, and Mayank Verma, and Shuichi Watanabe, and Christopher Tastad, and Yoko Asakura, and Atsushi Asakura
September 2015, Molecular and cellular biology,
Hiroyuki Hirai, and Mayank Verma, and Shuichi Watanabe, and Christopher Tastad, and Yoko Asakura, and Atsushi Asakura
February 2022, British poultry science,
Hiroyuki Hirai, and Mayank Verma, and Shuichi Watanabe, and Christopher Tastad, and Yoko Asakura, and Atsushi Asakura
February 2008, Blood,
Hiroyuki Hirai, and Mayank Verma, and Shuichi Watanabe, and Christopher Tastad, and Yoko Asakura, and Atsushi Asakura
May 1995, Journal of biochemistry,
Hiroyuki Hirai, and Mayank Verma, and Shuichi Watanabe, and Christopher Tastad, and Yoko Asakura, and Atsushi Asakura
February 2015, Oncotarget,
Copied contents to your clipboard!